Evidence map›Paper›PMID 37018411›Full record

ArticleScience advances2023

Inhibition of FAM46/TENT5 activity by BCCIPα adopting a unique fold.

Shun Liu, Hua Chen, Yan Yin, Defen Lu, Guoming Gao, Jie Li, Xiao-Chen Bai, Xuewu Zhang

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Fold-Switching Proteins.Annual review of biophysics · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. AlphaFold2 has more to learn about protein energy landscapes.bioRxiv : the preprint server for biology · 2023
    Article
  12. SSDraw: Software for generating comparative protein secondary structure diagrams.Protein science : a publication of the Protein Society · 2023
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Shun LiuDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-1766-2057
Hua ChenDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-8961-8151
Yan YinDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-5255-2064
Defen LuDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-6154-0364
Guoming GaoDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0001-6791-3902
Jie LiDepartment of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-1059-280X
Xiao-Chen BaiDepartment of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-4234-5686
Xuewu ZhangDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID 0000-0002-3634-6711
The University of Texas Southwestern Medical Center · US

Funding

Structural and functional analyses of the FAM46 proteins.R01CA220283 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI ZHANG, XUEWU · 2018 to 2022
$1.8M
Structural insights into the unique activation mechanisms of receptor tyrosine kinasesR01GM143158 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI BAI, XIAOCHEN · 2021 to 2024
$1.6M
NCI NIH HHS R01 CA220283NIGMS NIH HHS R01 GM143158
6 · The paper itself

Abstract

The FAM46 (also known as TENT5) proteins are noncanonical poly(A) polymerases (PAPs) implicated in regulating RNA stability. The regulatory mechanisms of FAM46 are poorly understood. Here, we report that the nuclear protein BCCIPα, but not the alternatively spliced isoform BCCIPβ, binds FAM46 and inhibits their PAP activity. Unexpectedly, our structures of the FAM46A/BCCIPα and FAM46C/BCCIPα complexes show that, despite sharing most of the sequence and differing only at the C-terminal portion, BCCIPα adopts a unique structure completely different from BCCIPβ. The distinct C-terminal segment of BCCIPα supports the adoption of the unique fold but does not directly interact with FAM46. The β sheets in BCCIPα and FAM46 pack side by side to form an extended β sheet. A helix-loop-helix segment in BCCIPα inserts into the active site cleft of FAM46, thereby inhibiting the PAP activity. Our results together show that the unique fold of BCCIPα underlies its interaction with and functional regulation of FAM46.

Indexed as

Nuclear ProteinsCalcium-Binding ProteinsCatalytic DomainCell Cycle ProteinsPolynucleotide AdenylyltransferaseProtein IsoformsCalcium-Binding ProteinsCell Cycle ProteinsNuclear ProteinsPolynucleotide AdenylyltransferaseProtein Isoforms

Identifiers

PMID37018411
PMCPMC10075960
OpenAlexW4362636772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.